組織工程和生物材料為基礎的再生醫療市場，規模，佔有率，趨勢，產業分析報告:各用途，各地區，2025年～2034年的市場預測

根據 Polaris Market Research 的最新研究，預計到 2034 年，組織工程和基於生物材料的再生醫學市場規模將達到 88.7948 億美元。本研究報告深入分析了當前的市場動態，並分析了未來的市場成長。

再生醫學已被證明是治療慢性疾病和臨床疾病的有效選擇。近年來，組織工程和再生醫學取得了顯著發展，並正在經歷快速變革。組織工程目前被認為是一種透過結合支架、細胞和生物活性分子來治療器官相關健康問題的有效工具。

個人化醫療的發展推動了對可針對每位患者進行個人化客製化的再生療法的需求。利用患者自身細胞培育組織和器官可顯著降低排斥風險，並改善癒合效果。如今，先進的生物材料可以根據個體的機械和生物需求進行工程設計，從而提高治療效果。精準醫療的趨勢與組織工程的核心競爭力完美契合，並正在推動其發展。

全球捐贈器官和組織的短缺，迫切需要找到替代方案。組織工程提供了一種極具前景的解決方案，它能夠利用患者自身細胞在實驗室中培育組織和器官，從而降低排斥風險並減少漫長的等待時間。基於生物材料的支架可支持細胞生長和組織形成，為移植手術的成功奠定了基礎。隨著移植供需缺口的不斷擴大，對再生醫學技術的需求變得更加迫切，刺激了市場的成長。

組織工程與以生物材料為基礎的再生醫學市場報告重點

受全球人口中骨骼、關節和軟骨相關疾病高發生率的推動，預計肌肉骨骼系統領域在預測期內的複合年增長率將達到 31.5%。

受全球慢性腎病和腎衰竭發病率上升的推動，腎臟病學領域預計將佔相當大的市場佔有率。

得益於先進的醫療基礎設施、強大的研究生態系統和大量的醫療支出，預計北美將在 2024 年主導組織工程和基於生物材料的再生醫學市場，佔全球收入的 55.80%。

受醫療保健需求成長、醫療基礎設施快速發展以及生物技術研究投資增加的推動，預計預測期內亞太市場複合年增長率將達到 32.3%。

全球組織工程和基於生物材料的再生醫學市場的主要公司包括 Aspect Biosystems Ltd.、Histogenics Corporation、MiMedx Group, Inc.、Organovo Holdings Inc.、Osiris Therapeutics, Inc.、Takara Bio Inc.、Tissue Regenix Group plc 和 Vericel Corporation。

目錄

第1章 簡介

第2章 摘要整理

第3章 調查手法

第4章 組織工程和生物材料為基礎的再生醫療市場洞察

• 組織工程和生物材料為基礎的再生醫療- 產業概述
• 組織工程和生物材料為基礎的再生醫療市場動態
  • 促進因素和機會
    • 全球投資不斷增加
    • 2024 年主要資助計畫範例
    • 全球資助類型（按年份）
    • 不斷擴展的全球臨床格局
    • 支架技術的進步
    • 不斷成長的需求重建外科和組織工程
    • 重建外科和組織工程的需求不斷增長
  • 阻礙與課題
    • 成本相對較高
    • 產生數據的差異
    • 無支架技術的興起
• PEST 分析
• COVID-19 影響分析
• 產業趨勢

第5章 組織工程和生物材料為基礎的再生醫療市場評估:各用途

• 簡介
• 肌肉骨骼
• 腎臟
• 肝臟

第6章 組織工程和生物材料為基礎的再生醫療市場評估:各地區

• 簡介
• 北美
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 義大利
• 亞太地區
  • 中國
  • 日本
  • 韓國
• 南美
• 中東·非洲

第7章 企業簡介

• Organovo Holdings Inc.
• Tissue Regenix Group plc
• Histogenics Corporation
• Aspect Biosystems Ltd.
• Vericel Corporation
• MiMedx Group, Inc.
• Takara Bio Inc.
• Osiris Therapeutics, Inc

第8章 客制化

• 組織工程市場上主要應用的大體的市場佔有率

The tissue engineering and biomaterial-based regenerative medicine market size is expected to reach USD 8,879.48 million by 2034, according to a new study by Polaris Market Research. The report "Tissue Engineering and Biomaterial-Based Regenerative Medicine Market Size, Share, Trends, Industry Analysis Report By Application (Musculoskeletal, Kidney, Liver), By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Regenerative medicine is proving to be a valuable treatment option for chronic and clinical medical conditions. Tissue engineering and regenerative medicine have greatly evolved in the recent past and have undergone rapid changes. Tissue engineering is now being considered as an effective tool to treat organ related health issues, through the combination of scaffolds, cells, and biologically active molecules.

The move toward personalized healthcare is driving demand for regenerative treatments that can be customized to individual patients. Using a patient's own cells to grow tissues or organs significantly reduces the chances of rejection and improves healing outcomes. Advanced biomaterials can now be engineered to match the mechanical and biological needs of each person, making treatments more effective. This trend toward precision medicine is aligning perfectly with the core capabilities of tissue engineering, thereby driving the growth.

The global shortage of donor organs and tissues has led to an urgent search for alternatives. Tissue engineering offers a promising solution by enabling the development of lab-grown tissues and organs using the patient's own cells. This reduces the risks of rejection and long waiting times. Biomaterial-based scaffolds help support cell growth and tissue formation, providing a foundation for successful transplants. The need for regenerative medicine technologies becomes even more critical as the gap between supply and demand for transplants continues to widen, fueling market growth.

Tissue Engineering and Biomaterial-Based Regenerative Medicine Market Report Highlights

The musculoskeletal segment is anticipated to register a CAGR of 31.5% during the forecast period, driven by the high prevalence of bone, joint, and cartilage-related disorders across the global population.

The kidney segment is expected to hold a notable share of the market, supported by the rising incidence of chronic kidney disease and kidney failure worldwide.

North America dominated the tissue engineering and biomaterial-based regenerative medicine market in 2024, accounting for 55.80% of the global revenue, fueled by its advanced healthcare infrastructure, strong research ecosystem, and substantial healthcare expenditures.

The Asia Pacific market is projected to register a CAGR of 32.3% during the forecast period, driven by increasing healthcare demand, rapid development of medical infrastructure, and rising investment in biotechnology research.

A few key players in the global tissue engineering and biomaterial-based regenerative medicine market are Aspect Biosystems Ltd.; Histogenics Corporation; MiMedx Group, Inc.; Organovo Holdings Inc.; Osiris Therapeutics, Inc.; Takara Bio Inc.; Tissue Regenix Group plc; and Vericel Corporation.

Polaris Market Research has segmented the tissue engineering and biomaterial-based regenerative medicine market report based on application and region:

By Application (Revenue - USD Million, 2020-2034)

Musculoskeletal

Kidney

Liver

By Regional Outlook (Revenue - USD Million, 2020-2034)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

Table of Contents

Chapter 1. Introduction

• 1.1 Report Description
  • 1.1.1 Objectives of the Study
  • 1.1.2 Market Scope
  • 1.1.3 Assumptions
• 1.2 Stakeholders

Chapter 2. Executive Summary

• 2.1 Market Highlights

Chapter 3. Research Methodology

• 3.1 Overview
  • 3.1.1 Data Mining
• 3.2 Data Sources
  • 3.2.1 Primary Sources
  • 3.2.2 Secondary Sources

Chapter 4. Tissue Engineering and Biomaterial-Based Regenerative Medicine Market Insights

• 4.1 Tissue Engineering and Biomaterial-Based Regenerative Medicine - Industry snapshot
• 4.2 Tissue Engineering and Biomaterial-Based Regenerative Medicine Market Dynamics
  • 4.2.1 Drivers and Opportunities
    • 4.2.1.1 Rising Investments across the globe
    • 4.2.1.1.1 Examples of key financing initiatives, 2024
    • 4.2.1.1.2 Total Global Financings Type by Year
    • 4.2.1.2 Widening Global Clinical Landscape
    • 4.2.1.3 Technological advancements in scaffold technology
    • 4.2.1.4 Increasing demand for body reconstruction procedures and tissue engineering
    • 4.2.1.5 Increasing demand for body reconstruction procedures and tissue engineering
  • 4.2.2 Restraints and Challenges
    • 4.2.2.1 Comparatively High Cost
    • 4.2.2.2 Inconsistency in data generated
    • 4.2.2.3 Advent of scaffold-free technology
• 4.3 Porter's Five Forces Analysis
  • 4.3.1 Bargaining Power of Suppliers (High)
  • 4.3.2 Threats of New Entrants: (Low)
  • 4.3.3 Bargaining Power of Buyers (Moderate)
  • 4.3.4 Threat of Substitute (Moderate)
  • 4.3.5 Rivalry among existing firms (Moderate)
• 4.4 PEST Analysis
• 4.5 Tissue Engineering and Biomaterial-Based Regenerative Medicine Market - Covid Impact Analysis
• 4.6 Tissue Engineering and Biomaterial-Based Regenerative Medicine Market - Industry Trends

Chapter 5. Tissue Engineering and Biomaterial-based Regenerative Medicine Market Assessment by Application

• 5.1 Introduction
• 5.2 Musculoskeletal
• 5.3 Kidney
• 5.4 Liver

Chapter 6. Tissue Engineering and Biomaterial-based Regenerative Medicine Market Assessment by Geography

• 6.1 Introduction
• 6.2 Tissue Engineering and Biomaterial-based Regenerative Medicine Market - North America
  • 6.2.1 Tissue Engineering and Biomaterial-based Regenerative Medicine Market - U.S.
  • 6.2.2 Tissue Engineering and Biomaterial-based Regenerative Medicine Market - Canada
• 6.3 Tissue Engineering and Biomaterial-based Regenerative Medicine Market - Europe
  • 6.3.1 Tissue Engineering and Biomaterial-based Regenerative Medicine Market - Germany
  • 6.3.2 Tissue Engineering and Biomaterial-based Regenerative Medicine Market - UK
  • 6.3.3 Tissue Engineering and Biomaterial-based Regenerative Medicine Market - France
  • 6.3.4 Tissue Engineering and Biomaterial-based Regenerative Medicine Market - Italy
• 6.4 Tissue Engineering and Biomaterial-based Regenerative Medicine Market - Asia Pacific
  • 6.4.1 Tissue Engineering and Biomaterial-based Regenerative Medicine Market - China
  • 6.4.2 Tissue Engineering and Biomaterial-based Regenerative Medicine Market - Japan
  • 6.4.3 Tissue Engineering and Biomaterial-based Regenerative Medicine Market - South Korea
• 6.5 Tissue Engineering and Biomaterial-based Regenerative Medicine Market - Latin America
• 6.6 Tissue Engineering and Biomaterial-based Regenerative Medicine Market - Middle East & Africa

Chapter 7. Company Profiles

• 7.1 Organovo Holdings Inc.
  • 7.1.1 Business Overview
  • 7.1.2 Financial Snapshot
  • 7.1.3 Products and Services
  • 7.1.4 Strategic Initiatives
• 7.2 Tissue Regenix Group plc
  • 7.2.1 Business Overview
  • 7.2.2 Financial Snapshot
  • 7.2.3 Products and Services
• 7.3 Histogenics Corporation
  • 7.3.1 Business Overview
  • 7.3.2 Products and Services
• 7.4 Aspect Biosystems Ltd.
  • 7.4.1 Business Overview
  • 7.4.2 Products and Services
  • 7.4.3 Strategic Initiatives
• 7.5 Vericel Corporation
  • 7.5.1 Business Overview
  • 7.5.2 Financial Snapshot
  • 7.5.3 Products and Services
  • 7.5.4 Strategic Initiatives
• 7.6 MiMedx Group, Inc.
  • 7.6.1 Business Overview
  • 7.6.2 Financial Snapshot
  • 7.6.3 Products and Services
  • 7.6.4 Strategic Initiatives
• 7.7 Takara Bio Inc.
  • 7.7.1 Business Overview
  • 7.7.2 Financial Snapshot
  • 7.7.3 Products and Services
  • 7.7.4 Strategic Initiatives
• 7.8 Osiris Therapeutics, Inc
  • 7.8.1 Business Overview
  • 7.8.2 Products and Services
  • 7.8.3 Strategic Initiatives

Chapter 8. Customization

• 8.1 Approximate Market Share of Major Applications in Tissue Engineering Market

List of Tables

• Table 1 Global Tissue Engineering and Biomaterial-based Regenerative Medicine Market, By Application, 2020 - 2034 (USD Million)
• Table 2 Global Tissue Engineering and Biomaterial-based Regenerative Medicine Market, by Musculoskeletal Applications, by Region, 2020 - 2034 (USD Million)
• Table 3 Global Tissue Engineering and Biomaterial-based Regenerative Medicine Market, by Kidney Applications, by Region, 2020 - 2034 (USD Million)
• Table 4 Global Tissue Engineering and Biomaterial-based Regenerative Medicine Market, by Liver Applications, by Region, 2020 - 2034 (USD Million)
• Table 5 Tissue Engineering and Biomaterial-based Regenerative Medicine Market Assessment, By Geography, 2020 - 2034 (USD Million)
• Table 6 North America: Tissue Engineering and Biomaterial-based Regenerative Medicine Market, 2020 - 2034 (USD Million)
• Table 7 North America: Tissue Engineering and Biomaterial-based Regenerative Medicine Market, By Application, 2020 - 2034 (USD Million)
• Table 8 U.S.: Tissue Engineering and Biomaterial-based Regenerative Medicine Market, 2020 - 2034 (USD Million)
• Table 9 U.S.: Tissue Engineering and Biomaterial-based Regenerative Medicine Market, By Application, 2020 - 2034 (USD Million)
• Table 10 Canada: Tissue Engineering and Biomaterial-based Regenerative Medicine Market, 2020 - 2034 (USD Million)
• Table 11 Canada: Tissue Engineering and Biomaterial-based Regenerative Medicine Market, By Application, 2020 - 2034 (USD Million)
• Table 12 Europe: Tissue Engineering and Biomaterial-based Regenerative Medicine Market, 2020 - 2034 (USD Million)
• Table 13 Europe: Tissue Engineering and Biomaterial-based Regenerative Medicine Market, By Application, 2020 - 2034 (USD Million)
• Table 14 Germany: Tissue Engineering and Biomaterial-based Regenerative Medicine Market, 2020 - 2034 (USD Million)
• Table 15 Germany: Tissue Engineering and Biomaterial-based Regenerative Medicine Market, By Application, 2020 - 2034 (USD Million)
• Table 16 UK: Tissue Engineering and Biomaterial-based Regenerative Medicine Market, 2020 - 2034 (USD Million)
• Table 17 UK: Tissue Engineering and Biomaterial-based Regenerative Medicine Market, By Application, 2020 - 2034 (USD Million)
• Table 18 France: Tissue Engineering and Biomaterial-based Regenerative Medicine Market, 2020 - 2034 (USD Million)
• Table 19 France: Tissue Engineering and Biomaterial-based Regenerative Medicine Market, By Application, 2020 - 2034 (USD Million)
• Table 20 Italy: Tissue Engineering and Biomaterial-based Regenerative Medicine Market, 2020 - 2034 (USD Million)
• Table 21 Italy: Tissue Engineering and Biomaterial-based Regenerative Medicine Market, By Application, 2020 - 2034 (USD Million)
• Table 22 Asia Pacific: Tissue Engineering and Biomaterial-based Regenerative Medicine Market, 2020 - 2034 (USD Million)
• Table 23 Asia Pacific: Tissue Engineering and Biomaterial-based Regenerative Medicine Market, By Application, 2020 - 2034 (USD Million)
• Table 24 China: Tissue Engineering and Biomaterial-based Regenerative Medicine Market, 2020 - 2034 (USD Million)
• Table 25 China: Tissue Engineering and Biomaterial-based Regenerative Medicine Market, By Application, 2020 - 2034 (USD Million)
• Table 26 Japan: Tissue Engineering and Biomaterial-based Regenerative Medicine Market, 2020 - 2034 (USD Million)
• Table 27 Japan: Tissue Engineering and Biomaterial-based Regenerative Medicine Market, By Application, 2020 - 2034 (USD Million)
• Table 28 South Korea: Tissue Engineering and Biomaterial-based Regenerative Medicine Market, 2020 - 2034 (USD Million)
• Table 29 South Korea: Tissue Engineering and Biomaterial-based Regenerative Medicine Market, By Application, 2020 - 2034 (USD Million)
• Table 30 Latin America: Tissue Engineering and Biomaterial-based Regenerative Medicine Market, 2020 - 2034 (USD Million)
• Table 31 Latin America: Tissue Engineering and Biomaterial-based Regenerative Medicine Market, By Application, 2020 - 2034 (USD Million)
• Table 32 Middle East & Africa: Tissue Engineering and Biomaterial-based Regenerative Medicine Market, 2020 - 2034 (USD Million)
• Table 33 Middle East & Africa: Tissue Engineering and Biomaterial-based Regenerative Medicine Market, By Application, 2020 - 2034 (USD Million)
• Table 34 Approximate Global Market Share of Major Applications in Tissue Engineering and Biomaterial-Based Regenerative Medicine Market, 2024, (%)

List of Figures

• Figure 1. Market Highlights
• Figure 2. Research Methodology: Top Down & Bottom Up Approach
• Figure 3. Market by Geography, 2024 & 2034 (USD Million)
• Figure 4. Global Corporate Partnerships, 2020 - 2034 (USD Million)
• Figure 5. Global Venture Capital Initiatives, 2020 - 2034 (USD Million)
• Figure 6. Global IPOs Initiatives, 2020 - 2034 (USD Million)
• Figure 7. Global Follow-On Financings, 2020 - 2034 (USD Million)
• Figure 8. Global Mergers & Acquisitions (Upfront Payment), 2020 - 2034 (USD Million)
• Figure 9. Total Clinical Trials Underway in 2024
• Figure 10. Porter's Five Forces
• Figure 11. Market by Application
• Figure 12. Global Tissue Engineering and Biomaterial-based Regenerative Medicine Market, By Application, 2024 & 2034 (% of total market)
• Figure 13. Tissue Engineering and Biomaterial-based Regenerative Medicine Market Assessment, By Geography, 2024 & 2034 (USD Million)